Senti Biosciences Files 2024 10-K

Ticker: SNTI · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1854270

Sentiment: neutral

Topics: 10-K, biotech, financials

TL;DR

Senti Bio's 2024 10-K is in. Check financials and business segments.

AI Summary

Senti Biosciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, previously known as Dynamics Special Purpose Corp., is in the biological products sector. The filing details its business activities and financial reporting segments for 2024 and 2023, including related and non-related party transactions.

Why It Matters

This filing provides a comprehensive overview of Senti Biosciences' financial performance and business operations for the fiscal year 2024, crucial for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: medium — As a biotech company, Senti Biosciences is subject to inherent risks related to research and development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is Senti Biosciences, Inc.'s primary business activity?

Senti Biosciences, Inc. is involved in Biological Products (No Diagnostic Substances) as indicated by its SIC code [2836].

When did Senti Biosciences, Inc. change its name from Dynamics Special Purpose Corp.?

The company changed its name from Dynamics Special Purpose Corp. on March 31, 2021.

What is the filing date of this 10-K?

This 10-K filing was made on March 20, 2025.

What period does this 10-K report cover?

This 10-K reports on the fiscal year ending December 31, 2024.

Where is Senti Biosciences, Inc. located?

Senti Biosciences, Inc.'s business address is 2 Corporate Drive, First Floor, South San Francisco, CA 94080.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding Senti Biosciences, Inc. (SNTI).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing